
    
      MDR bacteria were defined as Pseudomonas aeruginosa (P. aeruginosa), Enterobacter species,
      those not sensitive to second and third generation cephalosporins, Acinetobacter species,
      extended-spectrum Î²-lactamase (ESBL) Enterobacteriaceae such as Escherichia coli (E. coli)
      and Klebsiella pneumoniae (K. pneumoniae), Burkholderia cepacia (B. cepacia),
      Stenotrophomonas maltophilia (S. maltophilia), and methicillin resistant Staphylococcus
      aureus (MRSA).

      The criteria for HCAP is defined as follows: patients who had been hospitalized in an acute
      care hospital for two or more days within the past 90 days; residents of a nursing home or
      long-term care facility; recipients of recent intravenous antibiotic therapy, chemotherapy or
      wound care within the past 30 days; or patients who attended a hospital or hemodialysis
      clinic.
    
  